MTOR and hepatocellular carcinoma: However, another study has shown the loss of AIM2 activity promotes HCC due to the mammalian target of rapamycin (mTOR)-S6K1 (ribosomal protein S6 kinase β1 or p70S6K) pathway promoting proliferation, colony formation, and invasion of HCC cells (315).